EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins

Gary Potikyan1, Rupert O V Savene, Julie M Gaulden

  • 1Molecular Biology Institute, Jonsson Comprehensive Cancer Center, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90024, USA.

Cancer Research
|July 20, 2007
PubMed

Insights

Thrombospondins, natural angiogenesis inhibitors, are suppressed by EWS/FLI1 in Ewing sarcoma. Restoring thrombospondins reduced tumor growth and vascularization, indicating their therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Suppression of antiangiogenic factors is linked to malignancies.
  • Thrombospondins 1 and 2 are key inhibitors of angiogenesis regulated by oncogenes.

Purpose of the Study:

  • To investigate the role of thrombospondins in Ewing sarcoma.
  • To determine how EWS/ETS fusion oncoproteins regulate thrombospondins.

Main Methods:

  • Investigated EWS/FLI1 regulation of thrombospondins in cell lines.
  • Analyzed EWS/FLI1 DNA-binding domain and promoter interactions.
  • Assessed the impact of forced thrombospondin expression on tumor formation in vivo.

Main Results:

  • EWS/FLI1 fusion protein suppresses thrombospondin expression in Ewing sarcoma cells.
  • This suppression requires an intact EWS/FLI1 DNA-binding domain.
  • Forced thrombospondin expression inhibited tumor growth and reduced microvessel density in vivo.

Conclusions:

  • Thrombospondins play a significant role in Ewing sarcoma vascularization.
  • Targeting thrombospondin regulation offers potential therapeutic strategies for Ewing sarcoma.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...